Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllers

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Westrop, Samantha J ^a   Qazi, Nadeem A ^a   Pido Lopez, Jeffrey ^a   Nelson, Mark R ^a   Gazzard, Brian ^a   Gotch, Frances M ^a   Imami, Nesrina ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; NEF PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; PEPTIDE; VIRUS PROTEIN;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MALE; THYMUS; VIRUS LOAD; ADULT; AGED; CELL PROLIFERATION; FOLLOW UP; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; SPECIES DIFFERENCE; T LYMPHOCYTE; TIME; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; AGED; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; HIV ANTIGENS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; MALE; MIDDLE AGED; PEPTIDES; SPECIES SPECIFICITY; T-LYMPHOCYTES; THYMUS GLAND; TIME FACTORS; VIRAL PROTEINS;

EID: 65749112172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005474     Document Type: Article

References (39)

1. Pantaleo G, Fauci AS (1996) Immunopathogenesis of HIV infection. Annu Rev Microbiol 50: 825-854.
2. Deeks SG, Walker BD (2007) Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27: 406-416.
3. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, et al. (1997) Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278: 1447-1450.
4. Imami N, Pires A, Hardy G, Wilson J, Gazzard B, et al. (2002) A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection. J Virol 76: 9011-9023.
5. Williams MA, Bevan MJ (2007) Effector and memory CTL differentiation. Annu Rev Immunol 25: 171-192.
6. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, et al. (1998) Longlasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 351: 1682-1686.
7. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, et al. (2002) HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3: 1061-1068. Epub 2002 Oct 1067.
8. Lefrere JJ, Morand-Joubert L, Mariotti M, Bludau H, Burghoffer B, et al. (1997) Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood 90: 1133-1140.
9. Stebbing J, Bower M, Mandalia S, Nelson M, Gazzard B (2006) Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality. Clinical and Experimental Immunology 145: 271-276.
10. Harari A, Petitpierre S, Vallelian F, Pantaleo G (2004) Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103: 966-972.
11. Boaz MJ, Waters A, Murad S, Easterbrook PJ, Vyakarnam A (2002) Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J Immunol 169: 6376-6385.
12. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
13. Tilton JC, Luskin MR, Johnson AJ, Manion M, Hallahan CW, et al. (2007) Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load. J Virol 81: 2713-2725.
14. Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, et al. (2008) Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 197: 563-571.
15. Imami N, Westrop S, Cranage A, Burton C, Gotch F (2007) Combined use of cytokines, hormones and therapeutic vaccines during effective antiretroviral therapy. Future HIV Therapy 1: 171-179.
16. Resino S, Correa R, Bellon JM, Munoz-Fernandez MA (2003) Preserved immune system in long-term asymptomatic vertically HIV-1 infected children. Clin Exp Immunol 132: 105-112.
17. Ho Tsong Fang R, Khatissian E, Monceaux V, Cumont MC, Beq S, et al. (2005) Disease progression in macaques with low SIV replication levels: on the relevance of TREC counts. Aids 19: 663-673.
18. Burton CT, Gotch F, Imami N (2006) Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: Cocomitant assessment of perforin, IFN-γ and IL-4 Secretion. Journal of Immunological Methods 308: 216-230.
19. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, et al. (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695.
20. Pido-Lopez J, Burton C, Hardy G, Pires A, Sullivan A, et al. (2003) Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune). AIDS Res Hum Retroviruses 19: 103-109.
21. Aspinall R, Pido J, Andrew D (2000) A simple method for the measurement of sjTREC levels in blood. Mech Ageing Dev 121: 59-67.
22. Migueles SA, Laborico AC, Imamichi H, Shupert WL, Royce C, et al. (2003) The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J Virol 77: 6889-6898.
23. Bergholtz BO, Thorsby E (1977) Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility. Scand J Immunol 6: 779-786.
24. Pires A, Hardy G, Gazzard B, Gotch F, Imami N (2004) Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirs. J Acquir Immune Defic Syndr 36: 783-790.
25. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, et al. (2007) CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13: 46-53. Epub 2006 Dec 2017.
26. Imami N, Hardy G, Burton C, Pires A, Pido-Lopez J, et al. (2001) Immune responses and reconstitution in HIV-1 infected individuals: impact of antiretroviral therapy, cytokines and therapeutic vaccination. Immunol Lett 79: 63-76.
27. Bobbitt KR, Addo MM, Altfeld M, Filzen T, Onafuwa AA, et al. (2003) Rev activity determines sensitivity of HIV-1-infected primary T cells to CTL killing. Immunity 18: 289-299.
28. Lama J, Planelles V (2007) Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology 4: 52.
29. Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP (2000) The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol 18: 529-560.
30. Fernandez S, Nolan RC, Price P, Krueger R, Wood C, et al. (2006) Thymic function in severely immunodeficient HIV type 1-infected patients receiving stable and effective antiretroviral therapy. AIDS Res Hum Retroviruses 22: 163-170.
31. Hazenberg MD, Otto SA, Cohen Stuart JW, Verschuren MC, Borleffs JC, et al. (2000) Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 6: 1036-1042.
32. Douek D (2004) Thymic output and HIV infection: on the right TREC. Immunity 21: 744-745.
33. Dion ML, Poulin JF, Bordi R, Sylvestre M, Corsini R, et al. (2004) HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 21: 757-768.
34. Almeida AR, Borghans JA, Freitas AA (2001) T cell homeostasis: thymus regeneration and peripheral T cell restoration in mice with a reduced fraction of competent precursors. J Exp Med 194: 591-599.
35. Ladell K, Hellerstein MK, Cesar D, Busch R, Boban D, et al. (2008) Central memory CD8(+) T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression. J Immunol 180: 7907-7918.
36. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
37. Palmer S, Wiegand A, Miura T, Block B, Pereyra F, et al. (2008) Low-Level Viremia in HIV-1-Infected Patients Classified as "Elite Controllers" Compared to Patients on Suppressive Antiretroviral Therapy. 15th Annual Conference of Retroviruses and Opportunistic Infection. Boston, USA.
38. Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, et al. (2008) Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29: 1009-1021.
39. Blankson JN, Siliciano RF (2008) Elite suppression of HIV-1 replication. Immunity 29: 845-847.